Skip to main content
The BMJ logoLink to The BMJ
. 1990 Feb 3;300(6720):297–300. doi: 10.1136/bmj.300.6720.297

Microalbuminuria as predictor of increased mortality in elderly people.

E M Damsgaard 1, A Frøland 1, O D Jørgensen 1, C E Mogensen 1
PMCID: PMC1661920  PMID: 2106959

Abstract

OBJECTIVE--Correlation of the urinary albumin excretion rate and the risk of death among elderly subjects. DESIGN--216 Subjects aged 60-74 whose urinary albumin excretion rate had been determined were followed up 62-83 months later. SETTING--Municipality of Fredericia, Denmark. SUBJECTS--223 People who had been selected as control subjects for diabetics found during a systematic screening for diabetes of all people aged 60-74 living in the municipality of Fredericia, Denmark. Of these subjects, 216 had an extensive clinical and biochemical examination within a few weeks of selection. MAIN OUTCOME MEASURE--Death. RESULTS--The median urinary albumin excretion rate was 7.52 micrograms/min. Eight of those with a rate below the median died compared with 23 with a rate equal to or greater than the median (p = 0.0078). The median albumin excretion rate in the 31 who died was 15.00 micrograms/min. Cardiovascular disease was the most common cause of death in both groups. A multivariate regression analysis of survival data was performed using the proportional hazards model. Besides albumin excretion rate, male sex, serum creatinine concentration, and hypertension were found to be of prognostic value. CONCLUSIONS--The association between the albumin excretion rate and mortality that has been described in recent years in patients with diabetes mellitus may be present in elderly people in general, even when other known risk factors are taken into account.

Full text

PDF
297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castelli W. P., Garrison R. J., Wilson P. W., Abbott R. D., Kalousdian S., Kannel W. B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986 Nov 28;256(20):2835–2838. [PubMed] [Google Scholar]
  2. Damsgaard E. M., Frøland A., Green A., Hauge M. An alternative sampling approach to the study of diabetes prevalence. Scand J Soc Med. 1984;12(3):115–120. doi: 10.1177/140349488401200304. [DOI] [PubMed] [Google Scholar]
  3. Damsgaard E. M., Mogensen C. E. Microalbuminuria in elderly hyperglycaemic patients and controls. Diabet Med. 1986 Sep-Oct;3(5):430–435. doi: 10.1111/j.1464-5491.1986.tb00785.x. [DOI] [PubMed] [Google Scholar]
  4. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  5. Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
  6. Jarrett R. J., Viberti G. C., Argyropoulos A., Hill R. D., Mahmud U., Murrells T. J. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med. 1984 May;1(1):17–19. doi: 10.1111/j.1464-5491.1984.tb01915.x. [DOI] [PubMed] [Google Scholar]
  7. Kannel W. B., Stampfer M. J., Castelli W. P., Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J. 1984 Nov;108(5):1347–1352. doi: 10.1016/0002-8703(84)90763-4. [DOI] [PubMed] [Google Scholar]
  8. Kusumi R. K., Grover P. J., Kunin C. M. Rapid detection of pyuria by leukocyte esterase activity. JAMA. 1981 Apr 24;245(16):1653–1655. [PubMed] [Google Scholar]
  9. Mattock M. B., Keen H., Viberti G. C., el-Gohari M. R., Murrells T. J., Scott G. S., Wing J. R., Jackson P. G. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1988 Feb;31(2):82–87. doi: 10.1007/BF00395552. [DOI] [PubMed] [Google Scholar]
  10. Miles D. W., Mogensen C. E., Gundersen H. J. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest. 1970 Aug;26(1):5–11. doi: 10.3109/00365517009049206. [DOI] [PubMed] [Google Scholar]
  11. Mogensen C. E., Chachati A., Christensen C. K., Close C. F., Deckert T., Hommel E., Kastrup J., Lefebvre P., Mathiesen E. R., Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985;9(2):85–95. doi: 10.3109/08860228509088195. [DOI] [PubMed] [Google Scholar]
  12. Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. doi: 10.1056/NEJM198407123110204. [DOI] [PubMed] [Google Scholar]
  13. Mogensen C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984 Feb 9;310(6):356–360. doi: 10.1056/NEJM198402093100605. [DOI] [PubMed] [Google Scholar]
  14. Mogensen C. E., Schmitz A., Christensen C. K. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metab Rev. 1988 Aug;4(5):453–483. doi: 10.1002/dmr.5610040504. [DOI] [PubMed] [Google Scholar]
  15. Pyörälä K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987 Apr;3(2):463–524. doi: 10.1002/dmr.5610030206. [DOI] [PubMed] [Google Scholar]
  16. Pyörälä K., Savolainen E., Kaukola S., Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl. 1985;701:38–52. doi: 10.1111/j.0954-6820.1985.tb08888.x. [DOI] [PubMed] [Google Scholar]
  17. Schmitz A., Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med. 1988 Mar;5(2):126–134. doi: 10.1111/j.1464-5491.1988.tb00958.x. [DOI] [PubMed] [Google Scholar]
  18. Shearman C. P., Gosling P. Microalbuminuria and vascular permeability. Lancet. 1988 Oct 15;2(8616):906–907. doi: 10.1016/s0140-6736(88)92504-4. [DOI] [PubMed] [Google Scholar]
  19. Viberti G. Etiology and prognostic significance of albuminuria in diabetes. Diabetes Care. 1988 Nov-Dec;11(10):840–845. doi: 10.2337/diacare.11.10.840. [DOI] [PubMed] [Google Scholar]
  20. Welborn T. A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979 Mar-Apr;2(2):154–160. doi: 10.2337/diacare.2.2.154. [DOI] [PubMed] [Google Scholar]
  21. Yudkin J. S., Forrest R. D., Jackson C. A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988 Sep 3;2(8610):530–533. doi: 10.1016/s0140-6736(88)92657-8. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES